Skip to content

Skye Bioscience, Inc.

SKYE · XNAS

CIK 1516551fmd_11HGJVBXZW4PMA8YW9HJZ0NRSHManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Nov 01, 2011 to Jun 30, 2026, 61 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading